Luise Weigand

Chief Scientific Officer Zelluna Immunotherapy

Seminars

Tuesday 19th May 2026
C-Level Fireside Chat: Reflecting on Lessons from TCR Therapies to Drive Next-Generation Strategies
9:00 am
  • Identifying pivotal learnings that can sharpen development strategies and accelerate stronger clinical outcomes
  • Framing actionable insights that translate early proof-of-concept gains into durable, real-world clinical impact
  • Exploring critical knowledge gaps and defining high-value priorities that can shape the next-generation of TCR innovations
Luise Weigan - Zelluna - speaker photo